Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases-Reference-Cited by-同舟云学术

Phase 1b study of pasireotide, everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases

Published:2018-02-16 Issue:9 Volume:124 Page:1992-2000
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kim Hyun S.¹^ORCID,Shaib Walid L.²^ORCID,Zhang Chao³,Nagaraju Ganji Purnachandra²^ORCID,Wu Christina²,Alese Olatunji B.²,Chen Zhengjia³,Brutcher Edith²,Renfroe Meredith⁴,El-Rayes Bassel F.²^ORCID

Affiliation:

1. Division of Interventional Radiology, Yale Cancer Center; Yale School of Medicine; New Haven Connecticut

2. Department of Hematology and Oncology, Winship Cancer Institute; Emory University; Atlanta Georgia

3. Department of Biostatistics; Emory University; Atlanta Georgia

4. Clinical Trials Office, Winship Cancer Institute; Emory University; Atlanta Georgia

Funder

Cancer Institute in Atlanta, Georgia

Novartis Foundation for Sustainable Development

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Result of liver resection as treatment for metastases from noncolorectal cancer;Benevento;J Surg Oncol.,2000

2. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group;Rinke;J Clin Oncol.,2009

3. Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study;Caplin;Endocr Relat Cancer.,2016

4. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med.,2017

5. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas;Strosberg;Cancer.,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review;eClinicalMedicine;2023-10

2. Developments in interventional management of hepatic metastases from neuroendocrine tumours;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

3. Genetics of Pancreatic Neuroendocrine Tumors;Hematology/Oncology Clinics of North America;2022-10

4. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases;Cancers;2022-07-14

5. Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases;European Journal of Nuclear Medicine and Molecular Imaging;2021-12-07